E2F1 in gliomas: A paradigm of oncogene addiction

Cancer Letters

Volumn 263, Issue 2, 2008, Pages 157-163

  Alonso, Marta M ^a   Alemany, Ramon ^b   Fueyo, Juan ^a   Gomez Manzano, Candelaria ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

E2F1; Glioma; Oncogene addiction

Indexed keywords

TRANSCRIPTION FACTOR E2F1;

CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; DNA REPLICATION; E2F1 GENE; GLIOMA; HUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 41649086716     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.001     Document Type: Review

References (36)

1. Arber N., Doki Y., Han E.K., Sgambato A., Zhou P., Kim N.H., Delohery T., Klein M.G., Holt P.R., and Weinstein I.B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57 (1997) 1569-1574
2. Weinstein I.B., Begemann M., Zhou P., Han E.K., Sgambato A., Doki Y., Arber N., Ciaparrone M., and Yamamoto H. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clinical Cancer Res. 3 (1997) 2696-2702
3. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250
4. Johnson D.G., Cress W.D., Jakoi L., and Nevins J.R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91 (1994) 12823-12827
5. Alonso M.M., Fueyo J., Yung W.K., and Gomez-Manzano C. E2F1 and telomerase: alliance in the dark side. Cell Cycle 5 (2006) 930-935
6. Kovesdi I., Reichel R., and Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45 (1986) 219-228
7. Reichel R., Kovesdi I., and Nevins J.R. Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48 (1987) 501-506
8. Bandara L.R., and La Thangue N.B. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351 (1991) 494-497
9. Chellappan S.P., Hiebert S., Mudryj M., Horowitz J.M., and Nevins J.R. The E2F transcription factor is a cellular target for the RB protein. Cell 65 (1991) 1053-1061
10. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
11. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3 (2002) 11-20
12. Harbour J.W., and Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14 (2000) 2393-2409
13. de Bruin A., Maiti B., Jakoi L., Timmers C., Buerki R., and Leone G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 278 (2003) 42041-42049
14. Christensen J., Cloos P., Toftegaard U., Klinkenberg D., Bracken A.P., Trinh E., Heeran M., Di Stefano L., and Helin K. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res. 33 (2005) 5458-5470
15. Bandara L.R., Buck V.M., Zamanian M., Johnston L.H., and La Thangue N.B. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12 (1993) 4317-4324
16. Trimarchi J.M., Fairchild B., Wen J., and Lees J.A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 98 (2001) 1519-1524
17. Dimova D.K., and Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24 (2005) 2810-2826
18. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., and DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15 (2001) 1311-1333
19. Parr M.J., Manome Y., Tanaka T., Wen P., Kufe D.W., Kaelin Jr. W.G., and Fine H.A. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med. 3 (1997) 1145-1149
20. Fueyo J., Gomez-Manzano C., Yung W.K., Clayman G.L., Liu T.J., Bruner J., Levin V.A., and Kyritsis A.P. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 12 (1996) 103-110
21. Chintala S.K., Fueyo J., Gomez-Manzano C., Venkaiah B., Bjerkvig R., Yung W.K., Sawaya R., Kyritsis A.P., and Rao J.S. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene 15 (1997) 2049-2057
22. Fueyo J., Gomez-Manzano C., Yung W.K., Liu T.J., Alemany R., Bruner J.M., Chintala S.K., Rao J.S., Levin V.A., and Kyritsis A.P. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology 50 (1998) 1307-1315
23. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., and Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85 (1996) 537-548
24. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., Orkin S.H., and Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
25. Fueyo J., Gomez-Manzano C., Yung W.K., Liu T.J., Alemany R., McDonnell T.J., Shi X., Rao J.S., Levin V.A., and Kyritsis A.P. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med. 4 (1998) 685-690
26. Maandag E.C., van der Valk M., Vlaar M., Feltkamp C., O'Brien J., van Roon M., van der Lugt N., Berns A., and te Riele H. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13 (1994) 4260-4268
27. Yamasaki L., Bronson R., Williams B.O., Dyson N.J., Harlow E., and Jacks T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat. Genet. 18 (1998) 360-364
28. Symonds H., Krall L., Remington L., Saenz-Robles M., Lowe S., Jacks T., and Van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 (1994) 703-711
29. Pan H., Yin C., Dyson N.J., Harlow E., Yamasaki L., and Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell. 2 (1998) 283-292
30. Marino S., Vooijs M., van Der Gulden H., Jonkers J., and Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14 (2000) 994-1004
31. Olson M.V., Johnson D.G., Jiang H., Xu J., Alonso M.M., Aldape K.D., Fuller G.N., Bekele B.N., Yung W.K., Gomez-Manzano C., and Fueyo J. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 67 (2007) 4005-4009
32. Chakravarti A., Delaney M.A., Noll E., Black P.M., Loeffler J.S., Muzikansky A., and Dyson N.J. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin. Cancer Res. 7 (2001) 2387-2395
33. Alonso M.M., Fueyo J., Shay J.W., Aldape K.D., Jiang H., Lee O.H., Johnson D.G., Xu J., Kondo Y., Kanzawa T., Kyo S., Bekele B.N., Zhou X., Nigro J., McDonald J.M., Yung W.K., and Gomez-Manzano C. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J. Natl. Cancer Inst. 97 (2005) 1589-1600
34. Fueyo J., Gomez-Manzano C., Alemany R., Lee P.S., McDonnell T.J., Mitlianga P., Shi Y.X., Levin V.A., Yung W.K., and Kyritsis A.P. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19 (2000) 2-12
35. Alonso M.M., Cascallo M., Gomez-Manzano C., Jiang H., Bekele B.N., Perez-Gimenez A., Lang F.F., Piao Y., Alemany R., and Fueyo J. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res. 67 (2007) 8255-8263
36. Fueyo J., Alemany R., Gomez-Manzano C., Fuller G.N., Khan A., Conrad C.A., Liu T.J., Jiang H., Lemoine M.G., Suzuki K., Sawaya R., Curiel D.T., Yung W.K., and Lang F.F. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J. Natl. Cancer Inst. 95 (2003) 652-660